AF
VIR icon

Allworth Financial’s Vir Biotechnology VIR Stock Holding History

Allworth Financial’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8K Sell
1,448
-2,309
-61% -$22K ﹤0.01% 3443
2026
Q1 		$33.7K Sell
3,757
-573
-13% -$4.57K ﹤0.01% 2615
2025
Q4 		$26.1K Sell
4,330
-81
-2% -$482 ﹤0.01% 2631
2025
Q3 		$25.2K Buy
4,411
+769
+21% +$3.93K ﹤0.01% 2562
2025
Q2 		$18.4K Hold
3,642
– – ﹤0.01% 2573
2025
Q1 		$22.9K Sell
3,642
-267
-7% -$2.37K ﹤0.01% 1998
2024
Q4 		$41.2K Buy
3,909
+267
+7% +$2.11K ﹤0.01% 1675
2024
Q3 		$27.3K Sell
3,642
-106
-3% -$921 ﹤0.01% 1718
2024
Q2 		$37.6K Sell
3,748
-221
-6% -$2.12K ﹤0.01% 1512
2024
Q1 		$40.2K Sell
3,969
-42
-1% -$428 ﹤0.01% 1391
2023
Q4 		$40.4K Buy
4,011
+188
+5% +$1.72K ﹤0.01% 1279
2023
Q3 		$35.8K Buy
3,823
+1
+0% +$14 ﹤0.01% 1242
2023
Q2 		$93.8K Sell
3,822
-688
-15% -$17.3K ﹤0.01% 917
2023
Q1 		$105K Sell
4,510
-711
-14% -$18.2K ﹤0.01% 839
2022
Q4 		$132K Buy
5,221
+3
+0.1% +$74 ﹤0.01% 734
2022
Q3 		$101K Buy
5,218
+97
+2% +$2.47K ﹤0.01% 768
2022
Q2 		$130K Buy
5,121
+21
+0.4% +$490 ﹤0.01% 651
2022
Q1 		$131K Buy
5,100
+4,916
+2,672% +$146K ﹤0.01% 656
2021
Q4 		$8K Buy
+184
New +$7.21K ﹤0.01% 1484
2021
Q2 		– Sell
-65
Closed -$3K – 1672
2021
Q1 		$3K Buy
+65
New +$3.5K ﹤0.01% 1254

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Allworth Financial's VIR Position: Q2 2026 in Review

Allworth Financial reduced its Vir Biotechnology (VIR) stake by 61% in Q2 2026, selling an estimated $22K and leaving 1,448 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3443.

Allworth Financial first reported a position in VIR in Q1 2021 and has held it in 20 quarters since. The position peaked at $132K in Q4 2022. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Allworth Financial held 1,448 shares of Vir Biotechnology worth $14.8K as of Q2 2026.
  • Allworth Financial sold 2,309 Vir Biotechnology shares in Q2 2026, an estimated $22K.
  • Vir Biotechnology made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3443 holding.
  • Allworth Financial first reported a position in Vir Biotechnology in Q1 2021 and has held it in 20 quarters since.
  • Allworth Financial's Vir Biotechnology position peaked at $132K in Q4 2022.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.